Literature DB >> 20045427

Longitudinal changes in PON1 enzymatic activities in Mexican-American mothers and children with different genotypes and haplotypes.

Karen Huen1, Kim Harley, Asa Bradman, Brenda Eskenazi, Nina Holland.   

Abstract

The paraoxonase 1 (PON1) enzyme prevents low-density lipoprotein oxidation and also detoxifies the oxon derivatives of certain neurotoxic organophosphate (OP) pesticides. PON1 activity in infants is low compared to adults, rendering them with lower metabolic and antioxidant capacities. We made a longitudinal comparison of the role of genetic variability on control of PON1 phenotypes in Mexican-American mothers and their children at the time of delivery (n=388 and 338, respectively) and again 7 years later (n=280 and 281, respectively) using generalized estimating equations models. At age 7, children's mean PON1 activities were still lower than those of mothers. This difference was larger in children with genotypes associated with low PON1 activities (PON1(-108TT), PON1(192QQ), and PON1(-909CC)). In mothers, PON1 activities were elevated at delivery and during pregnancy compared to 7 years later when they were not pregnant (p<0.001). In non-pregnant mothers, PON1 polymorphisms and haplotypes accounted for almost 2-fold more variation of arylesterase (AREase) and chlorpyrifos-oxonase (CPOase) activity than in mothers at delivery. In both mothers and children, the five PON1 polymorphisms (192, 55, -108, -909, -162) explained a noticeably larger proportion of variance of paraoxonase activity (62-78%) than AREase activity (12.3-26.6%). Genetic control of PON1 enzymatic activity varies in children compared to adults and is also affected by pregnancy status. In addition to known PON1 polymorphisms, unidentified environmental, genetic, or epigenetic factors may also influence variability of PON1 expression and therefore susceptibility to OPs and oxidative stress. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045427      PMCID: PMC2846980          DOI: 10.1016/j.taap.2009.12.031

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  46 in total

Review 1.  Environmental toxicity, oxidative stress and apoptosis: ménage à trois.

Authors:  Rodrigo Franco; Roberto Sánchez-Olea; Elsa M Reyes-Reyes; Mihalis I Panayiotidis
Journal:  Mutat Res       Date:  2008-12-09       Impact factor: 2.433

Review 2.  Children's exposure to environmental pollutants and biomarkers of genetic damage. I. Overview and critical issues.

Authors:  Monica Neri; Stefano Bonassi; Lisbeth E Knudsen; Radìm J Sram; Nina Holland; Donatella Ugolini; Domenico Franco Merlo
Journal:  Mutat Res       Date:  2005-07-05       Impact factor: 2.433

3.  The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.

Authors:  Mira Rosenblat; Leonid Gaidukov; Olga Khersonsky; Jacob Vaya; Roni Oren; Dan S Tawfik; Michael Aviram
Journal:  J Biol Chem       Date:  2006-01-10       Impact factor: 5.157

4.  Preparation and characterization of dialkylphosphoryl-obidoxime conjugates, potent anticholinesterase derivatives that are quickly hydrolyzed by human paraoxonase (PON1192Q).

Authors:  J Stenzel; F Worek; P Eyer
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

Review 5.  Environmental hazards: evidence for effects on child health.

Authors:  Donald T Wigle; Tye E Arbuckle; Mark Walker; Michael G Wade; Shiliang Liu; Daniel Krewski
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007 Jan-Mar       Impact factor: 6.393

6.  Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.

Authors:  Wan-Fen Li; Chien-Wen Sun; Tain-Junn Cheng; Kuang-Hsi Chang; Chien-Jen Chen; Shu-Li Wang
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-05       Impact factor: 4.219

7.  Determinants of variation in human serum paraoxonase activity.

Authors:  D L Rainwater; S Rutherford; T D Dyer; E D Rainwater; S A Cole; J L Vandeberg; L Almasy; J Blangero; J W Maccluer; M C Mahaney
Journal:  Heredity (Edinb)       Date:  2008-10-29       Impact factor: 3.821

8.  Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma.

Authors:  Philip W Connelly; Graham F Maguire; Clive M Picardo; John F Teiber; Dragomir Draganov
Journal:  J Lipid Res       Date:  2007-09-28       Impact factor: 5.922

9.  Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns.

Authors:  Nina Holland; Clement Furlong; Maria Bastaki; Rebecca Richter; Asa Bradman; Karen Huen; Kenneth Beckman; Brenda Eskenazi
Journal:  Environ Health Perspect       Date:  2006-07       Impact factor: 9.031

10.  Validation of PON1 enzyme activity assays for longitudinal studies.

Authors:  Karen Huen; Rebecca Richter; Clement Furlong; Brenda Eskenazi; Nina Holland
Journal:  Clin Chim Acta       Date:  2008-12-24       Impact factor: 3.786

View more
  22 in total

1.  Prenatal exposure to organophosphate pesticides, maternal paraoxonase 1 genotype, and childhood neurodevelopment at 24 months of age in Shandong, China.

Authors:  Yiwen Wang; Yan Zhang; Lin Ji; Yijun Zhou; Rong Shi; Michihiro Kamijima; Jun Ueyama; Yu Gao; Ying Tian
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-25       Impact factor: 4.223

Review 2.  Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health.

Authors:  Nina Holland; Daneida Lizarraga; Karen Huen
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

3.  The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants.

Authors:  Mahmut Abuhandan; Alpay Cakmak; Abdullah Taskın; Emrah Karakaya; Abdurrahim Kocyigit; Hatip Kılıc
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

4.  Organophosphate pesticide levels in blood and urine of women and newborns living in an agricultural community.

Authors:  Karen Huen; Asa Bradman; Kim Harley; Paul Yousefi; Dana Boyd Barr; Brenda Eskenazi; Nina Holland
Journal:  Environ Res       Date:  2012-06-08       Impact factor: 6.498

5.  Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children.

Authors:  Karen Huen; Lisa Barcellos; Kenneth Beckman; Sherri Rose; Brenda Eskenazi; Nina Holland
Journal:  Environ Mol Mutagen       Date:  2011-03       Impact factor: 3.216

Review 6.  Developmental neurotoxicity of succeeding generations of insecticides.

Authors:  Yael Abreu-Villaça; Edward D Levin
Journal:  Environ Int       Date:  2016-11-28       Impact factor: 9.621

7.  Longitudinal assessment of chlorpyrifos exposure and effect biomarkers in adolescent Egyptian agricultural workers.

Authors:  Alice L Crane; Gaafar Abdel Rasoul; Ahmed A Ismail; Olfat Hendy; Matthew R Bonner; Michael R Lasarev; Manal Al-Batanony; Steven T Singleton; Khalid Khan; James R Olson; Diane S Rohlman
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-01-16       Impact factor: 5.563

Review 8.  Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Authors:  Lucio G Costa; Gennaro Giordano; Toby B Cole; Judit Marsillach; Clement E Furlong
Journal:  Toxicology       Date:  2012-07-31       Impact factor: 4.221

9.  Organophosphate pesticide exposure, PON1, and neurodevelopment in school-age children from the CHAMACOS study.

Authors:  Brenda Eskenazi; Katherine Kogut; Karen Huen; Kim G Harley; Maryse Bouchard; Asa Bradman; Dana Boyd-Barr; Caroline Johnson; Nina Holland
Journal:  Environ Res       Date:  2014-08-27       Impact factor: 6.498

10.  Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics.

Authors:  Kristine L Witt; Patricia G Moorman; Olga Kovalchuk; Nina Holland; Gladys Block; Paul R Andreassen
Journal:  Environ Mol Mutagen       Date:  2010 Oct-Dec       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.